Advanced Solid Tumor
772
262
336
172
Key Insights
Highlights
Success Rate
64% trial completion
Published Results
48 trials with published results (6%)
Research Maturity
172 completed trials (22% of total)
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 72/100
12.7%
98 terminated out of 772 trials
63.7%
-22.9% vs benchmark
0%
2 trials in Phase 3/4
28%
48 of 172 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 172 completed trials
Clinical Trials (772)
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Safety and Tolerability Study for T-1201 Injection 100 mg Kit in Patients With Advanced Solid Tumors
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
Phase 1/2 Study of Intravenous Injection of STX-003 in Advanced Solid Tumors as Monotherapy or in Combination With Pembrolizumab
SW-682 in Advanced Solid Tumors
A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
Imaging Study of [89Zr]DFO-YS5 for Cancer Detection
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
A Study to Assess a New Medicine Called IPN01195 When Administered Alone in Adults With Advanced Solid Tumours
A Phase 1, Dose-escalation Study of [225Ac]-FPI-2068 in Adult Patients With Advanced Solid Tumours
A Phase 1 Clinical Study of NXP900 in Subjects With Advanced Cancers
KPMNG Study of MOlecular Profiling Guided Therapy Based on Genomic Alterations in Advanced Solid Tumors II
First-in-Human Study of DS-3939a in Participants With Advanced Solid Tumors
Study of AVZO-021 in Patients With Advanced Solid Tumors
BGB-43395 Alone or as Part of Combination Therapies in Participants With Breast Cancer and Other Advanced Solid Tumors
A First-in-Human Study of BG-C0979 in Adults With Advanced Solid Tumors
A First-in-Human Study of BG-C0902 Alone and in Combination With Other Therapeutic Agents in Patients With Advanced Solid Tumors
A Study of BG-75098 Alone and in Combination With Other Agents in Adults With Advanced Solid Tumors
Pharmacokinetics Study of Larotinib in Subjects With Impaired Hepatic Function
A Study Investigating BGB-26808 Alone or in Combination With Tislelizumab in Participants With Advanced Solid Tumors